PURPOSE: The aim of this study is to evaluate the incidence of de novo malignancy after liver transplantation (LT) and compare with those among the general Chinese population. METHODS: A total of 466 patients who had a minimum follow-up time of 6 months were enrolled in the study. All data of medical records and follow up were retrospectively reviewed. RESULTS: The incidence rate of de novo malignancy was 3.0% (14 in 466 patients). The median elapsed time from transplant to the diagnosis of de novo malignancy was 42 months (range, 6 to 106 months). The cumulative risk for development of de novo malignancy was 1.6%, 2.7%, and 8.2% at 3, 5 and 10 years after LT, respectively. The patients were all male. The types of de novo tumors included digestive system tumor (8 in 14), lung cancer (2 in 14), urologic neoplasm (2 in 14), and hematologic malignant tumor (2 in 14). Over a mean follow-up of 24 months after diagnosis of de novo malignancy, 7 patients (50.0%) died; the overall 5-year patient survival rate was 54.5%. The relative risk of malignancy following LT was 9.5 folds higher than the general Chinese population. CONCLUSION: The relative risk of malignancy following LT was much higher than the general Chinese population. Digestive system tumor is the most common type of de novo malignancy after LT in China.
PURPOSE: The aim of this study is to evaluate the incidence of de novo malignancy after liver transplantation (LT) and compare with those among the general Chinese population. METHODS: A total of 466 patients who had a minimum follow-up time of 6 months were enrolled in the study. All data of medical records and follow up were retrospectively reviewed. RESULTS: The incidence rate of de novo malignancy was 3.0% (14 in 466 patients). The median elapsed time from transplant to the diagnosis of de novo malignancy was 42 months (range, 6 to 106 months). The cumulative risk for development of de novo malignancy was 1.6%, 2.7%, and 8.2% at 3, 5 and 10 years after LT, respectively. The patients were all male. The types of de novo tumors included digestive system tumor (8 in 14), lung cancer (2 in 14), urologic neoplasm (2 in 14), and hematologic malignant tumor (2 in 14). Over a mean follow-up of 24 months after diagnosis of de novo malignancy, 7 patients (50.0%) died; the overall 5-year patient survival rate was 54.5%. The relative risk of malignancy following LT was 9.5 folds higher than the general Chinese population. CONCLUSION: The relative risk of malignancy following LT was much higher than the general Chinese population. Digestive system tumor is the most common type of de novo malignancy after LT in China.
Authors: V Peyrègne; C Ducerf; M Adham; E de la Roche; N Berthoux; B Bancel; T Bizollon; J Baulieux Journal: Transplant Proc Date: 1998-06 Impact factor: 1.066
Authors: Anna Belloni-Fortina; Stefano Piaserico; Matteo Bordignon; Martina Gambato; Marco Senzolo; Francesco Paolo Russo; Andrea Peserico; Giuseppe De Matteis; Egle Perissinotto; Umberto Cillo; Alessandro Vitale; Mauro Alaibac; Patrizia Burra Journal: Acta Derm Venereol Date: 2012-07 Impact factor: 4.437
Authors: Gregory M Tiao; Nicola Bobey; Steven Allen; Neris Nieves; Maria Alonso; John Bucuvalas; Robert Wells; Frederick Ryckman Journal: J Pediatr Date: 2005-02 Impact factor: 4.406
Authors: H W Park; S Hwang; C S Ahn; K H Kim; D B Moon; T Y Ha; G W Song; D H Jung; G C Park; J M Namgoong; S Y Yoon; C S Park; Y H Park; H J Lee; S G Lee Journal: Transplant Proc Date: 2012-04 Impact factor: 1.066
Authors: M E Romero-Vargas; M Flores-Cortés; Z Valera; M A Gómez-Bravo; L Barrera-Pulido; F Pareja-Ciuró; J Serrano Díez-Canedo; I García; A Bernardos Journal: Transplant Proc Date: 2006-10 Impact factor: 1.066
Authors: Stephen L Guthery; James E Heubi; John C Bucuvalas; Thomas G Gross; Frederick C Ryckman; Maria H Alonso; William F Balistreri; Richard W Hornung Journal: Transplantation Date: 2003-04-15 Impact factor: 4.939
Authors: I Boin; M I Leonardi; R B Stucchi; E C Ataide; J R Almeida; R H Barros; L S Leonardi Journal: Transplant Proc Date: 2007-12 Impact factor: 1.066
Authors: Kerstin Herzer; Martina Sterneck; Martin-Walter Welker; Silvio Nadalin; Gabriele Kirchner; Felix Braun; Christina Malessa; Adam Herber; Johann Pratschke; Karl Heinz Weiss; Elmar Jaeckel; Frank Tacke Journal: J Clin Med Date: 2020-11-05 Impact factor: 4.241